These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 10651115

  • 21. Disturbance of Notch-1 and Wnt signalling proteins in neuroglial balloon cells and abnormal large neurons in focal cortical dysplasia in human cortex.
    Cotter D, Honavar M, Lovestone S, Raymond L, Kerwin R, Anderton B, Everall I.
    Acta Neuropathol; 1999 Nov; 98(5):465-72. PubMed ID: 10541869
    [Abstract] [Full Text] [Related]

  • 22. Axin prevents Wnt-3a-induced accumulation of beta-catenin.
    Kishida M, Koyama S, Kishida S, Matsubara K, Nakashima S, Higano K, Takada R, Takada S, Kikuchi A.
    Oncogene; 1999 Jan 28; 18(4):979-85. PubMed ID: 10023673
    [Abstract] [Full Text] [Related]

  • 23. Lithium induces morphological differentiation of mouse neuroblastoma cells.
    García-Pérez J, Avila J, Díaz-Nido J.
    J Neurosci Res; 1999 Jul 15; 57(2):261-70. PubMed ID: 10398304
    [Abstract] [Full Text] [Related]

  • 24. Taxol reduces cytosolic E-cadherin and beta-catenin levels in nasopharyngeal carcinoma cell line TW-039: cross-talk between the microtubule- and actin-based cytoskeletons.
    Lou PJ, Chen WP, Lin CT, Chen HC, Wu JC.
    J Cell Biochem; 2000 Sep 14; 79(4):542-56. PubMed ID: 10996845
    [Abstract] [Full Text] [Related]

  • 25. Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum.
    Alimohamad H, Rajakumar N, Seah YH, Rushlow W.
    Biol Psychiatry; 2005 Mar 01; 57(5):533-42. PubMed ID: 15737669
    [Abstract] [Full Text] [Related]

  • 26. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.
    Grimes CA, Jope RS.
    Prog Neurobiol; 2001 Nov 01; 65(4):391-426. PubMed ID: 11527574
    [Abstract] [Full Text] [Related]

  • 27. A novel role for glycogen synthase kinase-3 in Xenopus development: maintenance of oocyte cell cycle arrest by a beta-catenin-independent mechanism.
    Fisher DL, Morin N, Dorée M.
    Development; 1999 Feb 01; 126(3):567-76. PubMed ID: 9876185
    [Abstract] [Full Text] [Related]

  • 28. Nuclear localization of beta-catenin in adult mouse thalamus correlates with low levels of GSK-3beta.
    Lucas JJ, Hernández F, Avila J.
    Neuroreport; 1999 Sep 09; 10(13):2699-703. PubMed ID: 10511426
    [Abstract] [Full Text] [Related]

  • 29. Effect of adrenocorticotrophic hormone on the development of oestrogen-induced changes and hyperplasia formation in the mouse uterus.
    Gunin AG, Emelianov V, Tolmachev AS.
    Reproduction; 2002 Apr 09; 123(4):601-11. PubMed ID: 11914122
    [Abstract] [Full Text] [Related]

  • 30. Glucocorticoids inhibit cell cycle progression in differentiating osteoblasts via glycogen synthase kinase-3beta.
    Smith E, Coetzee GA, Frenkel B.
    J Biol Chem; 2002 May 17; 277(20):18191-7. PubMed ID: 11877389
    [Abstract] [Full Text] [Related]

  • 31. Glycogen synthase kinase-3β in patients with bipolar I disorder: results from a prospective study.
    Jacoby AS, Munkholm K, Vinberg M, Joaquim HG, Talib LL, Gattaz WF, Kessing LV.
    Bipolar Disord; 2016 Jun 17; 18(4):334-41. PubMed ID: 27325150
    [Abstract] [Full Text] [Related]

  • 32. Lithium regulates glycogen synthase kinase-3beta in human peripheral blood mononuclear cells: implication in the treatment of bipolar disorder.
    Li X, Friedman AB, Zhu W, Wang L, Boswell S, May RS, Davis LL, Jope RS.
    Biol Psychiatry; 2007 Jan 15; 61(2):216-22. PubMed ID: 16806104
    [Abstract] [Full Text] [Related]

  • 33. Different localization of tau protein kinase I/glycogen synthase kinase-3 beta from glycogen synthase kinase-3 alpha in cerebellum mitochondria.
    Hoshi M, Sato M, Kondo S, Takashima A, Noguchi K, Takahashi M, Ishiguro K, Imahori K.
    J Biochem; 1995 Oct 15; 118(4):683-5. PubMed ID: 8576078
    [Abstract] [Full Text] [Related]

  • 34. cis pT231-Tau Drives Neurodegeneration in Bipolar Disorder.
    Naserkhaki R, Zamanzadeh S, Baharvand H, Nabavi SM, Pakdaman H, Shahbazi S, Vosough M, Ghaedi G, Barzegar A, Mirtorabi D, Hedayatshodeh M, Ehsani E, Falahati M, Hajipour MJ, Shahpasand K.
    ACS Chem Neurosci; 2019 Mar 20; 10(3):1214-1221. PubMed ID: 30644730
    [Abstract] [Full Text] [Related]

  • 35. Expression of estrogen receptor-alpha, glucocorticoid receptor, beta-catenin and glycogen synthase kinase-3beta in the uterus of mice following long-term treatment with estrogen and glucocorticoid hormones.
    Gunin AG, Emelianov VU, Tolmachev AS.
    Eur J Obstet Gynecol Reprod Biol; 2003 Mar 26; 107(1):62-7. PubMed ID: 12593897
    [Abstract] [Full Text] [Related]

  • 36. Low GSK-3 activity in frontal cortex of schizophrenic patients.
    Kozlovsky N, Belmaker RH, Agam G.
    Schizophr Res; 2001 Oct 01; 52(1-2):101-5. PubMed ID: 11595396
    [Abstract] [Full Text] [Related]

  • 37. Localization and developmental changes of tau protein kinase I/glycogen synthase kinase-3 beta in rat brain.
    Takahashi M, Tomizawa K, Kato R, Sato K, Uchida T, Fujita SC, Imahori K.
    J Neurochem; 1994 Jul 01; 63(1):245-55. PubMed ID: 7515946
    [Abstract] [Full Text] [Related]

  • 38. Whether lithium inhibits glycogen synthase kinase (GSK)-3β activity in vivo in humans is still an open question.
    Agam G, Azab AN.
    Bipolar Disord; 2016 Aug 01; 18(5):464-7. PubMed ID: 27440170
    [No Abstract] [Full Text] [Related]

  • 39. Further evidence on the lack of association between glycogen synthase kinase 3beta gene polymorphisms and bipolar disorder.
    Scassellati C, Rotondo A, Bonvicini C, Rossi G, Cassano GB, Gennarelli M.
    Psychiatr Genet; 2007 Aug 01; 17(4):249-50. PubMed ID: 17621172
    [No Abstract] [Full Text] [Related]

  • 40. Marked alteration of phosphoinositide signaling-associated molecules in postmortem prefrontal cortex with bipolar disorder.
    Hino M, Kunii Y, Shishido R, Nagaoka A, Matsumoto J, Akatsu H, Hashizume Y, Hayashi H, Kakita A, Tomita H, Yabe H.
    Neuropsychopharmacol Rep; 2024 Mar 01; 44(1):121-128. PubMed ID: 38253804
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.